News: [Entry posted at 22nd December 2008 05:01 PM GMT] How much can you see with non-functioning visual cortex? A clinically blind man, with lesions on both sides of his visual cortex, was able to flawlessly navigate an obstacle course, a paper to be published tomorrow in Current Biology reports.
The ... Click to continue
|
News: [Entry posted at 18th December 2008 08:14 PM GMT] President-elect Barack Obama plans to nominate Harvard physicist John Holdren for role of presidential science advisor, according to Science's blog ... Click to continue
|
News: [Entry posted at 16th December 2008 04:27 PM GMT] Another case of a potentially fatal brain infection has been reported in a patient taking the multiple sclerosis drug Tysabri, the biotech who developed the drug announced yesterday.
This is the fourth case of infection, called progressive ... Click to continue
|
News: [Entry posted at 15th December 2008 06:39 PM GMT] Six California stem cell biotech companies received more than $5 million in funding last week from the state's stem cell funding body -- the California Institute for Regenerative Medicine (CIRM), according to a ... Click to continue
|
Comment on this news story
News: [Entry posted at 12th December 2008 03:53 PM GMT] Two employees in the pediatric neurological research department at Columbia University were arrested Wednesday (December 10) for scamming the institution out of more than $200,000.
John Bzdil, the former manager of the pediatric neurosciences ... Click to continue
|
News: [Entry posted at 10th December 2008 06:01 PM GMT] Parasites can confuse their hosts' immune system by switching the proteins they display on their surface. But how? The intestinal parasite Giardi lamblia harnesses RNA interference to target which surface proteins to shut down, a study published ... Click to continue
|
News: [Entry posted at 10th December 2008 04:25 PM GMT] Biotech industry executives are beseeching Congress today (10 Dec) for a temporary change in the tax code that would give some struggling biotech companies a cash boost.
The plan would funnel hundreds of millions of dollars to some biotechs in ... Click to continue
|
Comment on this news story
News: [Entry posted at 9th December 2008 09:16 PM GMT] The dearth of new drugs coming to market is forcing some drug companies -- and their investors -- to rethink R&D.
For instance, at the Novartis Institutes for Biomedical Research (NIBR), the focus has shifted from trying to develop the next ... Click to continue
|
News: [Entry posted at 4th December 2008 05:01 PM GMT] The immune tricks that keep HIV in check in long term non-progressors (LTNPs) -- people who carry the virus but don't get AIDS -- have been a mystery for decades. It turns out that T cells in LTNPs destroy the virus by punching holes in infected ... Click to continue
|
News: [Entry posted at 1st December 2008 04:25 PM GMT] The European Patent Office (EPO) issued its final ruling last week rejecting a much-contested embryonic stem cell patent -- a decision that will likely be cheered by researchers and jeered by biotechs.
The patent covered technology developed by ... Click to continue
|
|
Andrea's blog
Andrea Gawrylewski
Location:
Philadelphia, USA
Who am I?
Staff Writer
Previous months
>> January 2009
>> December 2008
>> November 2008
>> October 2008
>> September 2008
>> August 2008
>> July 2008
>> June 2008
>> May 2008
>> April 2008
>> March 2008
>> February 2008
>> January 2008
>> December 2007
>> November 2007
>> October 2007
>> September 2007
>> August 2007
>> April 2007
|
Register for FREE Online Access
Subscribe to the Magazine